Table 2: Effects of formoterol and AR42
treatments on muscles and adipose tissue weights in tumor-bearing rats.
|
Parameters |
Experimental groups |
||||
|
|
C |
T |
T+F |
T+A |
T+F+A |
|
Muscle
Weights |
|
|
|
|
|
|
GSN |
671 ± 9 |
568 ± 16 ### |
650 ± 11 *** |
569 ± 14 |
602 ± 13 |
|
Tibialis |
216 ± 3 |
188 ± 5 ### |
212 ± 4 *** |
179 ± 7 |
190 ± 6 |
|
Soleus |
48 ± 1 |
44 ± 1 # |
47 ± 1 * |
45 ± 2 |
42 ± 1 |
|
EDL |
52 ± 2 |
44 ±1 ### |
49 ± 1 *** |
42 ± 1 |
45 ± 1 |
|
Heart |
401 ± 14 |
348 ± 9 ## |
345 ± 18 |
342 ± 9 |
353 ± 31 |
Results
are mean ± SEM for the number of animals: C (12), T (13), T+F (13), T+A (4),
T+F+A (7). Values that are significantly different by the Student’s t-test from
the control group (C) are indicated by # p <0.05, ## p < 0.01, ### p <
0.001, and from the tumor non-treated animals group (T) are indicated by * p
<0.05, *** p < 0.001.
GSN:
Gastrocnemius muscle; EDL: Extensor Digitorum Longus; C: rats without tumor; T:
Tumor-bearing rats; T+F: Treated with Formoterol; T+A: Treated with AR42;
T+F+A: Treated with both Formoterol and AR42.